Analysis of immunohistochemical reactions of various PD-l1 clones in prostate adenocarcinoma

Prostate cancer (PC) is the most commonly diagnosed malignancy in men. The standard treatment for localized PC is radical prostatectomy, but recurrence is a significant problem in this case. The main prognostic markers of the disease recurrence are the Gleason score and the preoperative level of the prostate-specific antigen (PSA), which determines the need to identify some key molecules of the PC progression. This can be useful in identifying new prognostic markers or targeted treatments for this pathology.